Clinical Profile And Molecular Characterization Of Galactosemia In Brazil: Identification Of Seven Novel Mutations

dc.creatorGarcia
dc.creatorDaniel F.; Camelo
dc.creatorJose S.
dc.creatorJr.; Molfetta
dc.creatorGreice A.; Turcato
dc.creatorMarlene; Souza
dc.creatorCarolina F. M.; Porta
dc.creatorGilda; Steiner
dc.creatorCarlos E.; Silva
dc.creatorWilson A.
dc.creatorJr.
dc.date2016
dc.datemaio
dc.date2017-11-13T13:21:01Z
dc.date2017-11-13T13:21:01Z
dc.date.accessioned2018-03-29T05:54:24Z
dc.date.available2018-03-29T05:54:24Z
dc.identifierBmc Medical Genetics. Biomed Central Ltd, v. 17, p. , 2016.
dc.identifier1471-2350
dc.identifierWOS:000375686400001
dc.identifier10.1186/s12881-016-0300-8
dc.identifierhttps://bmcmedgenet.biomedcentral.com.ez88.periodicos.capes.gov.br/articles/10.1186/s12881-016-0300-8
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/327707
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1364732
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionClassical Galactosemia (CG) is an inborn error of galactose metabolism caused by the deficiency of the galactose-1-phosphate uridyltransferase enzyme. It is transmitted as an autosomal recessive disease and is typically characterized by neonatal galactose intolerance, with complications ranging from neonatal jaundice and liver failure to late complications, such as motor and reproductive dysfunctions. Galactosemia is also heterogeneous from a molecular standpoint, with hundreds of different mutations described in the GALT gene, some of them specific to certain populations, reflecting consequence of founder effect. Methods: This study reviews the main clinical findings and depicts the spectrum of mutations identified in 19 patients with CG, six with Duarte Galactosemia and one with type 2 Galactosemia in Brazil. Some individuals were diagnosed through expanded newborn screening test, which is not available routinely to all newborns. Results: The main classical Galactosemia mutations reported to date were identified in this study, as well as the Duarte variant and seven novel mutations -c.2 T > C (p.M1T), c.97C > A (p.R33S), c.217C > T (p.P73S), c.328 + 1G > A (IVS3 + 1G > A), c.377 + 4A > C (IVS4 + 4A > C), c.287_289delACA (p.N97del) and c.506A > C (p.Q169P). This was expected, given the high miscegenation of the Brazilian population. Conclusions: This study expands the mutation spectrum in GALT gene and reinforces the importance of early diagnosis and introduction of dietary treatment, what is possible with the introduction of Galactosemia in neonatal screening programs.
dc.description17
dc.description39
dc.descriptionNational Council for Scientific and Technological Development (CNPq) [146750/2010-1]
dc.descriptionCenter for Integrative System Biology - CISBi-NAP/USP [12.1.25441.01.2]
dc.descriptionCenter for Medical Genomics at the General Hospital of the Ribeirao Preto Medical School, University of Sao Paulo, Brazil
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.languageEnglish
dc.publisherBiomed Central Ltd
dc.publisherLondon
dc.relationBMC Medical Genetics
dc.rightsaberto
dc.sourceWOS
dc.subjectGalt
dc.subjectInborn Error Of Galactose Metabolism
dc.subjectMutation Screening
dc.titleClinical Profile And Molecular Characterization Of Galactosemia In Brazil: Identification Of Seven Novel Mutations
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución